Jump to section
To innovate solutions and provide expertise for today's most effective IBD treatment.
Few candidates hear
back within 2 weeks
SonarMD is a digital health platform focused on improving care for patients with chronic gastrointestinal (GI) conditions. By using AI and human support, it helps healthcare providers detect early signs of clinical deterioration for timely interventions.
Recent studies have shown that SonarMD significantly decreases hospital admission and emergency department visits for inflammatory bowel disease patients. One study found that users experienced 46% fewer emergency visits and 78% fewer hospital admissions after two years compared to a control group, underscoring the platform's effectiveness in lowering healthcare utilization.
Its success is also reflected in its growing partnerships with major health plans and gastroenterology practices. Alongside substantial funding, the company continues to expand its reach and is poised to play a key role in transforming chronic GI care into a more proactive and efficient model.
Steph
Company Specialist at Welcome to the Jungle
Jul 2024
$1m
EARLY VC
May 2023
$4.3m
EARLY VC
Beth Houck
(CEO)Before joining SonarMD, they led customer experience at SA Ignite. They hold an MBA from Duke University and a Bachelor's in Industrial Engineering from Northwestern University.
Julie Schokora
(COO)Before joining SonarMD, they held leadership positions at Evolent Health and Health Care Service Corp. and was a Senior Manager with Deloitte Consulting. They began their career as a Registered Nurse and maintains an active license.
Lawrence Kosinski
(Founder)Began their career in a small, three-physician GI practice and built it into the state's largest. Founder and CMO of VOCnomics, they also currently serve as the CMO at Jona and as a Board Member at the American Gastroenterological Association.